ABSTRACT. Three individual peptide sequences, EVSHPKVG, WVTTSNQW, and SGGSNRSP, which have potentials to bind to Newcastle disease virus (NDV), were identified by the biopanning method using phage display technology. The binding specificities of these peptides presented on phages were confirmed by ELISA competition assay using chicken anti-NDV antiserum. The synthetic peptides designed based on these results partially neutralized the infection of NDV in vitro. The peptide-motives identified here have the potential to lead to the identification of novel molecules that inhibit the NDV infection independent of the immune system. KEY WORDS: binding peptide, Newcastle disease virus, phage display.
Newcastle disease virus (NDV) is an avian enveloped virus belonging to the Paramyxoviridae family, genus Avulavirus, and a pathogen of Newcastle disease (ND). ND is known as one of the most serious avian diseases with a worldwide distribution that can cause severe economic losses in the poultry industry [1] . Several live and inactivated vaccines are available to control the outbreak of ND at present [6] . However, it is known that popular live vaccines, such as the B1 strain, can lead to some loses due to subclinical or acute respiratory disease, resulting in reduced weight gain and chick mortality, respectively [15] . Furthermore, in Japan, the number of small-scale poultry farmers who breed native chickens has increased as a result of the change in food culture. Such farmers tend to avoid vaccinations in consideration of the concerns of consumers over the safety of food, although lack of vaccinations results in a high mortality by NDV in poultry flocks. ND is still an economic problem causing severe losses to farmers and governments in developing countries. NDV can infect numerous kinds of unvaccinated fowl, including wild birds, and such infections seem to play a significant role in the spread of ND [1, 11] . For these reasons, the development of novel strategies to control NDV infections is desired.
Phage display technology can be used to select for and produce novel peptides that bind to the target molecules of interest. It allows rapid identification and amplification of the peptide ligands for a certain target molecule by the affinity of their specific-binding [3, 4, 16, 18] . Recently, it has been widely used in many fields, such as for identification and characterization of a peptide mimicking the epitope of HIV [5] and HIV-infected cells [10] , and identification of enzyme inhibitors [8] , immunodepressants [2] , and many antigens. This technique is superior to the methods with antibodies, which have been often used to detect such binding peptides, since a peptide displayed on the surface of filamentous bacteriophage is able to bind to the regions in a molecule that the immune system can not recognize. In other words, such a peptide can target a very small epitope: it searches for a binding site with a small amino acid loop while the large antibodies find an epitope of a molecule with two binding sites, a heavy chain and light chain. In addition, the phage display system is better than the methods with antibodies because it is inexpensive, easy to handle, and does not require much laboratory equipment [7, 9, 12] . In this study, aimed at the establishment of an alternative method of inhibiting the NDV infection independent of the immune system, the search for peptides that bind to and neutralize NDV was conducted using the phage display technology.
MATERIALS AND METHODS

Affinity selection and amplification of peptide library:
A heptapeptide library displayed on M13 filamentous phage (pSKAN8-HyA library [14] ) and Escherichia coli WK6λmutS was purchased from MoBiTec GmbH (Göttin-gen, Germany). The biopanning and amplification were essentially performed according to procedures provided by the manufacturer. Three rounds of biopanning were performed. Briefly, 100 µg/ml of the Ishii strain of NDV inactivated by diethyl ether and potassium periodate (purchased from Kaketsuken, Kumamoto, Japan) was coated onto 96-well microtiter plates and left at 4°C overnight. After being blocked with a blocking buffer (PBS, pH 7.2, containing 2% skim milk), coated and uncoated wells (as a negative control) were filled with the phagemid library [100 µl, 8 .0 × 10 10 -1.3 × 10 11 colony-forming units (cfu)/ml], which was 2-fold diluted with the blocking buffer, and incubated at room temperature for 1 hr. To remove phage binding nonspecifically, the wells were washed 10 times with PBS con-taining 0.5% Tween20 (PBST) during the 1st and 2nd round of biopanning. This washing step was changed during the 3rd round of biopanning: the wells were washed twice with PBST, incubated with the blocking buffer for 10 min, washed twice with PBST, incubated with the blocking buffer for 5 min, and then washed twice with PBST and twice with distilled deionized water. The bound phage was eluted with 100 µl 0.1 M glycine (pH 2.2) at room temperature for 15 min and neutralized with 6 µl of 2 M Tris. The titer of the phage-solution was determined by infecting E.
coli WK6λmutS with an aliquot (10 µl) of the phage-solution, followed by counting the colonies surviving on ampicillin-containing LB agar plates after incubation at 37°C overnight. The rest of the solution was used for amplification: phage-infected E. coli was grown in a liquid LB medium containing a M13K07 helper phage (2.0 × 10 11 cfu/ ml) at 37°C overnight. The phage pellets were then precipitated with 16.7% polyethylene glycol (MW=8,000) and 3.3 M NaCl, re-suspended in PBS, and mixed with chloroform to kill the E. coli. The titer of the phagemid after amplification was greater than 2.0 × 10 11 cfu/ml. Sequence analysis of phagemids: The nucleotide sequence encoding the hypervariable heptapeptide in a cloned phagemid was determined using a DyeDeoxy TM Cycle Sequencing System (Applied Biosystems, California, U.S.A) with 2 primers, #2897: 5'-GGAGGTCTA-G A T A A C G A G G -3 ' ( s e n s e ) a n d # 1 2 5 5 : 5 ' -GGGATTTTGCTAAACAAC-3' (anti-sense). Sequence analyses, including comparison with pSKAN8 (GenBank #X84307) and prediction of amino acid sequences, were performed using the GENETYX-WIN version 4.0 software package (Genetyx Corp., Tokyo, Japan).
Estimation of binding specificities of selected phage clones: Biopanning with monoclonal phages was performed in a similar manner as described above using monoclonal instead of polyclonal phage-solutions. A competitive phagemid ELISA was essentially performed according to the pSKAN system protocols. Briefly, inactivated NDV (Ishii strain, 100 µg/ml) was coated onto 96-well microtiter plates, and left at 4°C overnight. After being blocked with blocking buffer, the wells were filled with chicken anti-NDV antiserum (1:10 or 1:100 diluted, Kaketsuken), left for 1 hr at 37°C, washed three times with PBST, filled with the monoclonal phage-solutions 2-fold diluted with the blocking buffer, incubated at room temperature for 1 hr, and then washed twice with PBST. After incubation with peroxidase-labeled anti-M13 phage pVIII antibody (1:5,000 diluted, Amersham Pharmacia Biotech, New Jersey, U.S.A.), the absorbance of each well at a wavelength of 490 nm was measured by an ELISA reader (model 550, BioRad, California, U.S.A.).
NDV neutralization assay with the synthetic peptides: Decapeptides were synthesized that were designed based on the DNA sequences of the phagemids encoding peptides that bind specifically to NDV (Sigma-Genosys, Hokkaido, Japan; Table 2 ). These synthetic peptides were dissolved in DMSO and diluted with PBS. The diluted peptides were incubated with 200 TCID 50 of NDV (Komarov strain) at 37°C for 2 hr. The mixture was transferred to a monolayer of chicken embryo fibroblasts (CEF) in a flat-bottom 96-well culture plate (maintained in Eagle's Modified Essential Medium supplemented with 0.6% tryptose phosphate broth and 0.2% calf serum), and incubated at 37°C for 72 hr in a 5% CO 2 atmosphere. Ten µl of Alamar Blue TM (Nalgene, New York, U.S.A.) was added to each well, and incubation was continued for a further 4 hr. After measuring absorbance wavelengths of 570 and 595 nm, the percentage of surviving cells was calculated using a formula described in the Alamar BlueTM instruction manual.
Hemagglutination inhibition (HI) test: A conventional HI test was performed to determine whether the synthetic peptides can inhibit hemagglutination by NDV. Briefly, 25 µl of each synthetic peptide that had been 2-fold serially diluted with PBS was placed in the wells of 96-well plates.
Then, 1~2HA/25 µl of the inactivated Ishii strain of NDV (Kaketsuken) was added to each well and incubated at room temperature for 2 hr. Subsequently, 50 µl of prepared 0.5% chicken red blood cells were added into each well and allowed to incubate 1 hr at room temperature before hemagglutination activity was observed. The HI titer was determined using the well with the highest serum dilution in which a clear button was seen.
RESULTS
Selection of peptides specifically binding to NDV by biopanning:
Whole inactivated NDV was used as target molecules for biopanning with the aim of obtaining various peptides that bind not only to general surface molecules, HN and F proteins, of NDV, but also to the regions where immunoglobulin cannot access. After 3 rounds of biopanning, eluted phages from the NDV (+) wells re-infected with E. coli WK6λmutS formed 22 colonies, while the ones from the NDV (-) wells formed only 1 colony.
According to the nucleotide sequences of the phagemids obtained, these 23 colonies were composed of 12 clones. The deduced amino acid sequences of the hypervariable heptapeptides of these phagemids are shown in Table 1 . The nucleotide sequence of the phagemids derived from the NDV (-) wells corresponded to that of phagemid clone No. 3. The phagemids exhibiting stop codons or an excessive nucleotide within the hypervariable region, such as clones No. 3, 19, and 21, cannot express hybrid proteins including heptapeptide (as described in a manufacturer's protocol). On the other hand, as a result of sequence analyses of more than 100 phagemids from the NDV (-) wells after the 2nd round of biopanning, the phagemids whose nucleotide sequences were identical to those of phagemid clones No. 1, 2, 3, 6, 9, 11, and 15 were detected. These results indicated that phagemid clones No. 4, 5, and 8 could be specific to NDV even though no common amino acid sequences were found among them, while the others would be non-specific clones.
Estimation of binding specificities of selected phage clones: To examine the binding specificities of the peptides encoded by phagemid clones No. 4, 5, and 8, to NDV, each of the clones was amplified and the resultant monoclonal phages were used for biopanning (Fig. 1) . The washing procedure was the same as that for the 3rd round of the selection steps. The titers of phagemid clones No. 4, 5, and 8 derived from the NDV (+) wells were 40-50 times higher than those from the NDV (-) wells. However, the titer of pSKAN8, which is the original vector of the pSKAN8-HyA library without the fusion protein, from the NDV (+) wells was similar to that from the NDV (-) wells.
In the next experiment, binding specificity to NDV of phage-displayed peptides was assessed by competitive phagemid ELISA using chicken anti-NDV antiserum as a competitor (Fig. 2) . The OD 490 values of phagemid clones No. 4, 5, and 8 without antiserum were 0.9-1.25, and much higher than those of the negative control, 0.31-0.39. Furthermore, the anti-NDV antiserum inhibited the binding of these phages to NDV in a dose-dependent manner, whereas pSKAN8 showed little specificity to NDV. These results showed that these 3 peptides bind specifically to NDV in phages.
Characterization of peptides binding to NDV: Figures 1  and 2 showed that pSKAN8 has the potential to bind to NDV even though its affinity is very low, raising the possibility that part of the capsid protein expressed on the surface of the phage particle, except for the hypervariable region, could interact with NDV with low affinity. For this reason, synthetic peptides were prepared that were designed based on the nucleotide sequences of the hypervariable heptapeptide regions of phagemid clones No. 4, 5, and 8, and used for further experiments ( Table 2) . As a control, synthetic Nacetyl-D-glucosamine (GlcNAc)-mimicking peptide was used that is specific to an epitope of cytokeratin 14 and that reacts with both human anti-GlcNAc mAbs and GlcNAcspecific plant lectins [13, 17] . To investigate the inhibition efficiency of these synthetic peptides to NDV infection, NDV neutralization assay was performed using the Komarov strain (Fig. 3) . We chose the Komarov strain, a mesogenic strain, for the neutralization assay because it produces a clearer CPE than the Ishii strain and because it is known that NDV exists as a single serotype based on neutralizing and cross-protective analyses [1] . Only 15% of the cells survived after the inoculation of NDV in the presence of any concentration of the GlcNAc-mimicking peptide. On the other hand, the percentages of surviving cells after the inoculation of NDV treated with the peptides designed based on the phagemid clones were higher than either those without the peptides and those with the control GlcNAcmimicking peptides, and increased in a dose-dependent manner. These results show that these 3 synthetic peptides derived from phagemid clones neutralized, at least partially, the infection of NDV in vitro. However, none of these peptides inhibited hemagglutination by the inactivated Ishii strain of NDV as determined by the HI test (data not shown).
DISCUSSION
Clarifying the mechanism of specific interaction among biological molecules, for instance an antigen-antibody reaction, is an elemental and essential step in studying normal physiological function, disease prevention, and treatment. Phage display technology has been used successfully in numerous applications over the past decade [2, 5, 8, 10] . In addition, recently, a peptide-motif that can bind to the white spot syndrome virus of shrimp (WSSV) and inhibit WSSV infection was identified [19] . Thus, it is reasonable to choose this technique in the process of creating novel molecules that can specifically bind to NDV.
The purpose of this study was to select phage-displayed peptides that can bind specifically to NDV and inhibit the NDV infection. As a result of biopanning using whole inactivated virus as a target molecule, 3 individual heptapeptide sequences, EVSHPKVG (phagemid clone No. 4), WVTTSNQW (No. 5) and SGGSNRSP (No. 8) were identified as specific motives binding to NDV. Each of the binding-specificities was confirmed by one-round biopanning with monoclonal phage (Fig. 1) and competitive phagemid ELISA using anti-M13 antibody and chicken anti-NDV antiserum (Fig. 2) . Furthermore, synthetic peptides designed based on the DNA sequences of the heptapeptides partially neutralized the NDV infection in vitro (Fig. 3) . It is very likely that their binding sites on the surface of NDV are different from each other because the 3 peptides did not have any common amino acid sequences among them (Table 1) . Further experiments should be conducted to identify their binding sites in detail. It was also shown that none of the synthetic peptides inhibited hemagglutination by NDV. These results suggest that these 3 synthetic peptides do not interact with active sites in the HN protein, and that one of the candidates for their binding sites could be the F protein. In addition, large amounts (100-300 µg/ml) of the synthetic peptides were required to partially neutralize the NDV infection in vivo (Fig. 3 A, B, and C) , showing that their neutralization activities are not enough for clinical application. Therefore, in the future, it will be necessary to modify these peptide sequences, such as substitution of amino acids, to improve their abilities to bind to NDV and to inhibit the NDV infection. It is also important to examine the protective efficacies of them against NDV in vivo. Constant intake of compounds containing these 3 peptidemotives has the potentials to provide birds with resistance against NDV infection independent of the immune system. For instance, the development of an expression system of these peptides into grain used for feeding, such as an "eatable oral vaccine", is applicable not only to fowl, but also to wild birds.
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